We are live on ! Find out more
CE

Clark Estates Portfolio holdings

AUM $430M Turnover 31.13%
1-Year Est. Return 9.71%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+9.71%
3 Year Est. Return
+47.82%
5 Year Est. Return
+44.64%
10 Year Est. Return
+195.24%
AUM
$434M
AUM Growth
+$17.5M
Cap. Flow
-$3.16M
Cap. Flow %
-0.73%
Top 10 Hldgs %
52.76%
Holding
108
New
11
Increased
17
Reduced
16
Closed
18
Avg Time Held
2.5 years
Top 10 Avg Time Held
1 year
Top 20 Avg Time Held
1.4 years

Top Buys

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$25.8M
2
HSIC icon
Henry Schein
HSIC
+$9.7M
3
UL icon
Unilever
UL
+$3.76M
4
BBY icon
Best Buy
BBY
+$2.9M
5
SONY icon
Sony
SONY
+$2.81M

Top Sells

Rank Stock Value
1
ECML icon
Euclidean Fundamental Value ETF
ECML
+$15M
2
AVNS icon
Avanos Medical
AVNS
+$11.8M
3
IQV icon
IQVIA
IQV
+$7.5M
4
SOLV icon
Solventum
SOLV
+$6.56M
5
MDT icon
Medtronic
MDT
+$5.24M

Sector Composition

Rank Sector Weight
1 Healthcare 29.82%
2 Miscellaneous 21.8%
3 Technology 13.51%
4 Communication Services 11.78%
5 Consumer Staples 7.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ECML icon
1
Euclidean Fundamental Value ETF
ECML
$123M
$66.7M 15.37%
1,722,782
-396,700
-19% -$15M
2023 Q2
12 quarters
VEA icon
2
Vanguard FTSE Developed Markets ETF
VEA
$229B
$26.4M 6.1%
+371,060
New +$25.8M
2026 Q2
0 quarters
UL icon
3
Unilever
UL
$143B
$22.2M 5.13%
370,000
+65,000
+21% +$3.76M
2021 Q4
18 quarters
DIS icon
4
Walt Disney
DIS
$205B
$19.2M 4.44%
200,000
– –
2025 Q2
4 quarters
AMRZ icon
5
Amrize Ltd
AMRZ
$21.8B
$17.3M 3.99%
325,000
+40,000
+14% +$2.17M
2025 Q3
3 quarters
SONY icon
6
Sony
SONY
$158B
$16.5M 3.82%
825,000
+133,400
+19% +$2.81M
2024 Q3
7 quarters
HLN icon
7
Haleon
HLN
$40.2B
$15.9M 3.66%
1,700,000
+300,000
+21% +$2.79M
2022 Q3
15 quarters
SOLV icon
8
Solventum
SOLV
$15.1B
$15.4M 3.56%
200,000
-90,000
-31% -$6.56M
2025 Q3
3 quarters
BLCO icon
9
Bausch + Lomb
BLCO
$7.54B
$14.6M 3.36%
881,000
+56,000
+7% +$890K
2022 Q3
15 quarters
WMG icon
10
Warner Music
WMG
$16.9B
$14.5M 3.34%
535,000
-115,000
-18% -$3.42M
2025 Q4
2 quarters
HSIC icon
11
Henry Schein
HSIC
$9.5B
$11.3M 2.6%
135,000
+127,000
+1,588% +$9.7M
2026 Q1
1 quarter
IQV icon
12
IQVIA
IQV
$43.7B
$10.1M 2.32%
52,185
-43,015
-45% -$7.5M
2025 Q1
5 quarters
STTK icon
13
Shattuck Labs
STTK
$474M
$9.9M 2.29%
1,430,167
-45,481
-3% -$284K
2020 Q4
22 quarters
MDT icon
14
Medtronic
MDT
$132B
$7.04M 1.62%
90,000
-65,000
-42% -$5.24M
2022 Q1
17 quarters
WLY icon
15
John Wiley & Sons Class A
WLY
$2.54B
$4.58M 1.06%
94,400
+27,400
+41% +$1.15M
2023 Q3
11 quarters
DDD icon
16
3D Systems Corp
DDD
$255M
$4.28M 0.99%
1,418,614
– –
2013 Q2
52 quarters
SNN icon
17
Smith & Nephew
SNN
$13.1B
$4.13M 0.95%
143,500
-76,500
-35% -$2.38M
2023 Q1
13 quarters
MD icon
18
Pediatrix Medical
MD
$2.45B
$3.88M 0.89%
153,000
+24,000
+19% +$546K
2023 Q4
10 quarters
SUPN icon
19
Supernus, Inc. Common Stock
SUPN
$6.17B
$3.79M 0.87%
92,300
– –
2024 Q3
7 quarters
CPRX icon
20
DELISTED
Catalyst Pharmaceutical
CPRX
$3.58M 0.83%
113,918
– –
2023 Q3
11 quarters
HALO icon
21
Halozyme
HALO
$11.4B
$3.51M 0.81%
44,868
– –
2024 Q4
6 quarters
MO icon
22
Altria Group
MO
$131B
$3.5M 0.81%
48,613
– –
2020 Q1
25 quarters
CROX icon
23
Crocs
CROX
$7.49B
$3.49M 0.8%
28,900
– –
2022 Q1
17 quarters
BBY icon
24
Best Buy
BBY
$21.8B
$3.32M 0.76%
+43,700
New +$2.9M
2026 Q2
0 quarters
BIIB icon
25
Biogen
BIIB
$37.5B
$3.31M 0.76%
15,300
– –
2024 Q3
7 quarters

Similar funds

Clark Estates's Q2 2026 Portfolio in Review

As of Q2 2026, Clark Estates held 108 positions worth $434M, up 4.2% from $416M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Clark Estates's Q2 2026 filing shows 11 new, 17 increased, 16 reduced and 18 closed positions. Its largest new stake was Vanguard FTSE Developed Markets ETF: 371,060 shares worth $26.4M. The largest sale was Euclidean Fundamental Value ETF, an estimated $15M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 34% a quarter earlier, followed by Miscellaneous and Technology.

  • Clark Estates's largest Q2 2026 buy was Vanguard FTSE Developed Markets ETF: 371,060 shares worth $26.4M.
  • Clark Estates added most to Henry Schein in Q2 2026, an estimated $9.7M increase.
  • Clark Estates's biggest Q2 2026 reduction was Euclidean Fundamental Value ETF, cutting an estimated $15M.
  • Clark Estates fully exited Avanos Medical in Q2 2026, selling an estimated $11.8M.
  • Clark Estates's ten largest holdings make up 53% of its $434M portfolio in Q2 2026.
  • Clark Estates opened 11 new positions and closed 18 in Q2 2026.
  • Clark Estates's portfolio value rose 4.2% quarter-over-quarter to $434M.

Based on Clark Estates's 13F filing for Q2 2026, filed 5 Aug 2026.